| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.34 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |